Cargando…

TREM2 in Neurodegenerative Diseases

TREM2 variants have been identified as risk factors for Alzheimer’s disease (AD) and other neurodegenerative diseases (NDDs). Because TREM2 encodes a receptor exclusively expressed on immune cells, identification of these variants conclusively demonstrates that the immune response can play an active...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jay, Taylor R., von Saucken, Victoria E., Landreth, Gary E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541421/ https://www.ncbi.nlm.nih.gov/pubmed/28768545 http://dx.doi.org/10.1186/s13024-017-0197-5

Ejemplares similares

The effect of amyloid on microglia-neuron interactions before plaque onset occurs independently of TREM2 in a mouse model of Alzheimer’s disease
por: von Saucken, Victoria E., et al.
Publicado: (2020)

The Trem2 R47H variant confers loss-of-function-like phenotypes in Alzheimer’s disease
por: Cheng-Hathaway, Paul J., et al.
Publicado: (2018)

TREM2 in CNS homeostasis and neurodegenerative disease
por: Painter, Meghan M., et al.
Publicado: (2015)

TREM2 deficiency eliminates TREM2(+) inflammatory macrophages and ameliorates pathology in Alzheimer’s disease mouse models
por: Jay, Taylor R., et al.
Publicado: (2015)

TREM Receptors Connecting Bowel Inflammation to Neurodegenerative Disorders
por: Natale, Gianfranco, et al.
Publicado: (2019)

TREM2 splice isoforms generate soluble TREM2 species that disrupt long-term potentiation
por: Moutinho, Miguel, et al.
Publicado: (2023)

Trem2 Y38C mutation and loss of Trem2 impairs neuronal synapses in adult mice
por: Jadhav, Vaishnavi S., et al.
Publicado: (2020)

Function of TREM1 and TREM2 in Liver-Related Diseases
por: Sun, Huifang, et al.
Publicado: (2020)

Association between Cerebrospinal Fluid Soluble TREM2, Alzheimer’s Disease and Other Neurodegenerative Diseases
por: Zhou, Wenchuan, et al.
Publicado: (2023)

TREM2 dependent and independent functions of microglia in Alzheimer’s disease
por: Hou, Jinchao, et al.
Publicado: (2022)

New insights into the role of TREM2 in Alzheimer’s disease
por: Gratuze, Maud, et al.
Publicado: (2018)

Neurodegenerative disease mutations in TREM2 reveal a functional surface and distinct loss-of-function mechanisms
por: Kober, Daniel L, et al.
Publicado: (2016)

Neurodegenerative Disease–Associated Variants in TREM2 Destabilize the Apical Ligand-Binding Region of the Immunoglobulin Domain
por: Dean, Hunter B., et al.
Publicado: (2019)

Plasma sTREM2: a potential marker of cerebrovascular injury in neurodegenerative disorders
por: Rodriguez-Vieitez, Elena, et al.
Publicado: (2021)

A good gut feeling on Sarm1-mediated axon degeneration
por: von Saucken, Victoria E., et al.
Publicado: (2021)

TREM2 Protein Expression Changes Correlate with Alzheimer's Disease Neurodegenerative Pathologies in Post‐Mortem Temporal Cortices
por: Lue, Lih‐Fen, et al.
Publicado: (2014)

TREM2 regulates innate immunity in Alzheimer’s disease
por: Li, Jiang-Tao, et al.
Publicado: (2018)

TREM-1, TREM-2 and their association with disease severity in patients with COVID-19
por: Fan, Ruyue, et al.
Publicado: (2023)

Alzheimer's disease risk alleles in TREM2 illuminate innate immunity in Alzheimer's disease
por: Golde, Todd E, et al.
Publicado: (2013)

TREM2 deficiency exacerbates tau pathology through dysregulated kinase signaling in a mouse model of tauopathy
por: Bemiller, Shane M., et al.
Publicado: (2017)

TREM2 ectodomain and its soluble form in Alzheimer’s disease
por: Yang, Jiaolong, et al.
Publicado: (2020)

TREM2 brain transcript-specific studies in AD and TREM2 mutation carriers
por: Del-Aguila, Jorge L., et al.
Publicado: (2019)

The microglial NADPH oxidase complex as a source of oxidative stress in Alzheimer's disease
por: Wilkinson, Brandy L, et al.
Publicado: (2006)

Peripheral macrophages not ADept at amyloid clearance
por: Jay, Taylor, et al.
Publicado: (2015)

The biology of TREM receptors
por: Colonna, Marco
Publicado: (2023)

The Role of APOE and TREM2 in Alzheimer′s Disease—Current Understanding and Perspectives
por: Wolfe, Cody M., et al.
Publicado: (2018)

TREM-1; Is It a Pivotal Target for Cardiovascular Diseases?
por: Kouassi, Kouassi T., et al.
Publicado: (2018)

Tumor-Infiltrating Myeloid Cells Co-Express TREM1 and TREM2 and Elevated TREM-1 Associates With Disease Progression in Renal Cell Carcinoma
por: Ford, Jill W., et al.
Publicado: (2022)

Association of rs2062323 in the TREM1 gene with Alzheimer's disease and cerebrospinal fluid‐soluble TREM2
por: Wang, Zuo‐Teng, et al.
Publicado: (2023)

Exploring the Impact of TREM2 in Tumor-Associated Macrophages
por: Khantakova, Darya, et al.
Publicado: (2022)

TMEM59 interacts with TREM2 and modulates TREM2-dependent microglial activities
por: Liu, Zhaoji, et al.
Publicado: (2020)

Neuroinflammatory CSF biomarkers MIF, sTREM1, and sTREM2 show dynamic expression profiles in Alzheimer’s disease
por: Hok-A-Hin, Yanaika S., et al.
Publicado: (2023)

Microglial TYROBP/DAP12 in Alzheimer’s disease: Transduction of physiological and pathological signals across TREM2
por: Haure-Mirande, Jean-Vianney, et al.
Publicado: (2022)

The ratio of urinary TREM-1/TREM-2 mRNA expression in chronic kidney disease and renal fibrosis
por: Cao, Yuhan, et al.
Publicado: (2021)

Oncogenic Pathways in Neurodegenerative Diseases
por: Varela, Luis, et al.
Publicado: (2022)

Cerebrospinal fluid neurogranin and TREM2 in Huntington’s disease
por: Byrne, Lauren M., et al.
Publicado: (2018)

TREM2-Dependent Effects on Microglia in Alzheimer’s Disease
por: Zhou, Yingyue, et al.
Publicado: (2018)

Plasmonic Interferometers as TREM2 Sensors for Alzheimer’s Disease
por: Li, Dingdong, et al.
Publicado: (2021)

Targeting TREM2 for Parkinson’s Disease: Where to Go?
por: Li, Xiao-xian, et al.
Publicado: (2021)

TREM2 as an evolving therapeutic target in Alzheimer’s disease
por: George, Jacob
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hahts92qu2v72s7r3qovicstv9